|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
|
|---|---|---|---|---|---|
| Net loss | |||||
| Operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used for operations: | |||||
| Depreciation and amortization | |||||
| Depreciation | |||||
| Equity-based compensation | |||||
| Amortization of debt issuance costs | |||||
| Provision for bad debts ̶ net | |||||
| Provision for slow-moving, obsolete and lower of cost or net realizable value inventories ̶ net | |||||
| Foreign exchange losses on intercompany transactions ̶ net | |||||
| Gain from sale-leaseback of property and equipment | |||||
| Loss (gain) from disposal of property and equipment ̶ net | |||||
| Deferred income taxes | |||||
| Changes in assets and liabilities, excluding effects of foreign currency translation adjustments: | |||||
| Decrease in accounts receivable | |||||
| Decrease in net investment in sales-type leases | |||||
| Increase in inventories | |||||
| Increase in prepaid expenses and other assets | |||||
| (Decrease) increase in accounts payable | |||||
| Decrease in deferred revenue and customer prepayments | |||||
| Decrease in accrued expenses and other liabilities | |||||
| Increase in contract liabilities | |||||
| Net cash used for operating activities | |||||
| Investing activities | |||||
| Capital expenditures | |||||
| Net cash provided by investing activities | |||||
| Financing activities | |||||
| Payments on capital leases | |||||
| Proceeds from borrowings on long-term debt | |||||
| Payments on long-term debt | |||||
| Proceeds from related party revolving credit facility | |||||
| Payments on related party revolving credit facility | |||||
| Proceeds from at-the-market offerings of common stock, net of issuance costs | |||||
| Taxes related to the net share settlement of equity-based awards | |||||
| Debt issuance costs | |||||
| Proceeds from exercise of employee stock options | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Other | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net change in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental disclosure of cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosure of noncash investing and financing activities | |||||
| Transfer of internally developed 3D printing machines from inventories to property and equipment for internal use or leasing activities | |||||
| Transfer of internally developed 3D printing machines from property and equipment to inventories for sale | |||||
| Property and equipment included in assets held for sale | |||||
| Property and equipment included in accounts payable | |||||
| Property and equipment reclassified as assets held for sale | |||||
| Property and equipment acquired through financing arrangements | |||||
| At-the-market offering issuance costs included in accounts payable | |||||
Loading...